Herb Wiley, the guitarist for Rye Coalition and The Black Hollies, has been diagnosed with amyotrophic lateral sclerosis (ALS ...

Brad Smith, an Arizona husband and father with ALS, has become the third person to receive Neuralink, the brain implant made ...

Prilenia Therapeutics has signed a partnership and licence agreement with Ferrer to jointly develop and commercialise ...

Another apparent victim of CTE who still survives is Corwin Brown. A standout defensive back at the University of Michigan ...

VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment ...

Bradford Smith, who has ALS, became the first person with the condition to use Neuralink to type with brainpower alone.

Ferrer’s R&D work focuses on neurological and pulmonary diseases, and the Spanish pharma has bought into ALS assets in the ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...

The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...

An amyotrophic lateral sclerosis (ALS) diagnosis is often viewed as getting a death sentence. After diagnosis, people with ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...